Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$16.95 - $27.04 $47,460 - $75,712
-2,800 Reduced 28.0%
7,200 $194,000
Q1 2024

May 15, 2024

SELL
$11.38 - $19.03 $20,484 - $34,254
-1,800 Reduced 15.25%
10,000 $183,000
Q4 2023

Feb 14, 2024

SELL
$6.29 - $15.72 $90,576 - $226,368
-14,400 Reduced 54.96%
11,800 $144,000
Q3 2023

Nov 14, 2023

BUY
$14.99 - $32.65 $373,251 - $812,985
24,900 Added 1915.38%
26,200 $392,000
Q2 2023

Aug 14, 2023

SELL
$29.76 - $46.14 $8,928 - $13,842
-300 Reduced 18.75%
1,300 $42,000
Q1 2023

May 15, 2023

BUY
$38.09 - $57.79 $30,472 - $46,232
800 Added 100.0%
1,600 $62,000
Q4 2022

Feb 14, 2023

SELL
$40.54 - $56.2 $239,186 - $331,580
-5,900 Reduced 88.06%
800 $42,000
Q3 2022

Nov 14, 2022

SELL
$36.98 - $49.2 $432,665 - $575,640
-11,700 Reduced 63.59%
6,700 $302,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.